Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease

Kidney International

Volumn 83, Issue 6, 2013, Pages 1169-1176

  Rule, Andrew D ^a   Bailey, Kent R ^a   Lieske, John C ^a   Peyser, Patricia A ^b   Turner, Stephen T ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chronic kidney disease; Clinical; Creatinine; Epidemiology; Glomerular filtration rate

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; IOTALAMIC ACID; TRIACYLGLYCEROL; URIC ACID;

ACCURACY; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 84882240321     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.7     Document Type: Article

References (37)

1. Peralta CA, Katz R, Sarnak MJ et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol 2011; 22: 147-155.
2. Peralta CA, Shlipak MG, Judd S et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011; 305: 1545-1552.
3. Inker LA, Schmid CH, Tighiouart H et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29.
4. Mathisen UD, Melsom T, Ingebretsen OC et al. Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol 2011; 22: 927-937.
5. Menon V, Shlipak MG, Wang X et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Int Med 2007; 147: 19-27.
6. Tangri N, Inker LA, Tighiouart H et al. Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol 2012; 23: 351-359.
7. Bhavsar NA, Appel LJ, Kusek JW et al. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis 2011; 58: 886-893.
8. Hsu CY, Propert K, Xie D et al. Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol 2011; 22: 1931-1937.
9. Rule AD, Bergstralh EJ, Slezak JM et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006; 69: 399-405.
10. Lewis J, Greene T, Appel L et al. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 2004; 15: 3175-3183.
11. Keevil BG, Kilpatrick ES, Nichols SP et al. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44: 1535-1539.
12. Rule AD, Bailey KR, Schwartz GL et al. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 2009; 75: 1071-1078.
13. Murata K, Baumann NA, Saenger AK et al. Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol 2011; 6: 1963-1972.
14. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular fIltration rate: accuracy in good health and in chronic kidney disease. Ann Inter Med 2004; 141: 929-937.
15. Earley A, Miskulin D, Lamb EJ et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Inter Med 2012; 156: 785-795.
16. Jacobsson B, Lignelid H, Bergerheim US. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology 1995; 26: 559-564.
17. Knight EL, Verhave JC, Spiegelman D et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421.
18. Lafarge JC, Naour N, Clement K et al. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 2010; 92: 1580-1586.
19. Staun-Ram E, Miller A. Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-beta and role played in cell migration. J Neuroimmunol 2011; 232: 200-206.
20. Melsom T, Mathisen UD, Ingebretsen OC et al. Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care 2011; 34: 1546-1551.
21. Wuerzner G, Pruijm M, Maillard M et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis 2010; 56: 303-312.
22. Palatini P. Moderate or vigorous exercise? Which best helps prolong life? J Cardiovasc Med (Hagerstown) 2006; 7: 721-725.
23. Tonelli M, Klarenbach SW, Lloyd AM et al. Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. Kid Int 2011; 80: 1306-1314.
24. Shlipak MG, Sarnak MJ, Katz R et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060.
25. Sarnak MJ, Katz R, Stehman-Breen CO et al. Cystatin C concentration as a risk factor for heart failure in older adults.[see comment][summary for patients in]. Ann Inter Med 2005; 142: 497-505.
26. Wu CK, Lin JW, Caffrey JL et al. Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey). J Am Coll Cardiol 2010; 56: 1930-1936.
27. Park M, Hsu CY, Li Y et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012; 23: 1725-1734.
28. Hiramoto JS, Katz R, Peralta CA et al. Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2012; 60: 225-232.
29. Welles CC, Schafer AL, Vittinghoff E et al. Urine calcium excretion, cardiovascular events, and mortality in outpatients with stable coronary artery disease (from the Heart and Soul Study). Am J Cardiol 2012; 110: 1729-1734.
30. Peyser PA, Bielak LF, Chu JS et al. Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 2002; 106: 304-308.
31. Maher JE, Raz JA, Bielak LF et al. Potential of quantity of coronary artery calcification to identify new risk factors for asymptomatic atherosclerosis. Am J Epidemiol 1996; 144: 943-953.
32. Wilson DM, Bergert JH, Larson TS et al. GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis 1997; 30: 646-652.
33. Rule AD, Jacobson DJ, McGree ME et al. Longitudinal changes in postvoid residual and voided volume among community dwelling men. J Urol 2005; 174: 1317-1321.
34. Larsson A, Hansson LO, Flodin M et al. Calibration of the Siemens cystatin C immunoassay has changed over time. Clin Chem 2011; 57: 777-778.
35. Inker LA, Eckfeldt J, Levey AS et al. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis 2011; 58: 682-684.
36. DuBois D, DuBois E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871.
37. Levey AS, Coresh J, Greene T et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772. Diseases Diseases